Dow Down0.62% Nasdaq Down0.94%

GlaxoSmithKline plc (GSK)

-NYSE
42.87 Down 0.49(1.14%) 3:29PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:47.00
Median Target:48.00
High Target:49.00
Low Target:44.00
No. of Brokers:3

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 30, 2016CitigroupUpgradeNeutralBuy
Feb 26, 2016Cantor FitzgeraldInitiated Hold
Oct 20, 2015Credit SuisseUpgradeUnderperformNeutral
Sep 15, 2015Exane BNP ParibasUpgradeUnderperformNeutral
Sep 8, 2015BofA/MerrillUpgradeUnderperformNeutral
Jun 26, 2015LiberumUpgradeSellHold
Jun 4, 2015Morgan StanleyDowngradeOverweightEqual-Weight
Apr 23, 2014ArgusUpgradeHoldBuy
May 28, 2013Deutsche BankUpgradeHoldBuy
Jan 11, 2011JefferiesUpgradeHoldBuy

More Upgrades & Downgrades for GSK

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2222
Buy0000
Hold2222
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.